The Joe Tippens fenbendazole protocol is a self-treatment regimen that involves taking 222mg of fenbendazole three consecutive days per week, combined with vitamin E, CBD oil, and curcumin. Joe Tippens, a cancer patient who claimed remission while using this protocol in 2016, sparked widespread interest in repurposing this veterinary antiparasitic drug. While his story remains anecdotal and no clinical trials have validated this protocol for cancer treatment, thousands of people now follow variations of this regimen.

This guide breaks down the exact protocol as described by Tippens, the rationale behind each component, and practical considerations for anyone researching this approach.

What Is the Joe Tippens Protocol?

Joe Tippens developed his protocol after being diagnosed with stage 4 small cell lung cancer in 2016. Doctors gave him three months to live. After a veterinarian suggested he try fenbendazole based on preliminary research, Tippens added it to his treatment regimen alongside conventional therapy. When scans showed no evidence of disease, he attributed his results partly to the fenbendazole protocol and began sharing his experience online.

The protocol has four components. First, 222mg of fenbendazole taken orally three days in a row, followed by four days off. Second, vitamin E at 800 IU daily (with mixed tocopherols). Third, CBD oil at approximately 25mg daily. Fourth, curcumin at 600mg daily on an empty stomach. Tippens emphasized consistency and never altered the dosing based on body weight or disease progression.

The original formulation used Panacur C canine dewormer, which contains 222mg fenbendazole per packet. Each packet serves as one day's dose. Many people now use pharmaceutical-grade fenbendazole products like Wormentel 888mg, splitting tablets to achieve the 222mg dose or adjusting to higher doses like 444mg based on their research and healthcare guidance.

This protocol gained attention not through medical journals but through patient forums, YouTube videos, and Tippens' blog "My Cancer Story Rocks." His case remains uncontrolled and anecdotal. We cannot separate the effects of fenbendazole from his concurrent immunotherapy, radiation, and other treatments. No peer-reviewed study has replicated his results.

Exact Dosing Schedule and Timing

The standard Joe Tippens protocol follows a specific weekly pattern. Take 222mg of fenbendazole Monday, Tuesday, and Wednesday. Take nothing Thursday through Sunday. Repeat this cycle indefinitely. Tippens took the dose with food, typically in the morning with a meal containing some fat to potentially improve absorption.

Why 222mg specifically? This dose originated from the Panacur C packet size, not from pharmacokinetic calculations. The antiparasitic dose for dogs is approximately 50mg per kilogram of body weight for three consecutive days. For a 150-pound human (68kg), this would equal about 3,400mg daily, far exceeding the Tippens protocol dose. The 222mg represents roughly 3mg per kilogram for a 70kg person, well below the veterinary deworming dose.

Some people adjust this base protocol. A few double the dose to 444mg three days weekly, reasoning that higher doses appear in laboratory studies showing anticancer effects. Others take 222mg daily without breaks, concerned that four days off might reduce effectiveness. A small subset follows a 222mg six days on, one day off pattern. These variations lack clinical validation.

Timing matters less than consistency. Whether you take fenbendazole morning or evening makes no documented difference. Taking it with fatty food may increase absorption, as fenbendazole has poor water solubility. Yogurt, cheese, peanut butter, or any meal with 10-15 grams of fat works. Avoid taking fenbendazole on an empty stomach, as this reduces absorption and may increase stomach upset.

Duration varies by individual goals. Tippens continued the protocol for years after his remission, treating it as maintenance. Some people cycle on for three months, then off for one month. Others follow it short-term while researching options. No data establishes an optimal duration because no controlled study exists.

The Complete Supplement Stack

The Joe Tippens protocol includes three supplements alongside fenbendazole. Each serves a proposed purpose, though evidence supporting these combinations comes from cell studies and theory, not human trials.

Vitamin E at 800 IU daily uses the mixed tocopherol form, not alpha-tocopherol alone. Tippens believed vitamin E protected normal cells from oxidative stress while cancer cells remained vulnerable. The 800 IU dose exceeds the recommended dietary allowance of 22 IU but falls below the upper limit of 1,500 IU from supplements. Take vitamin E with a meal containing fat. Avoid synthetic dl-alpha-tocopherol and choose d-alpha-tocopherol with mixed tocopherols for the full vitamin E family.

CBD oil at 25mg daily came from Tippens' personal experimentation. He used full-spectrum CBD, not CBD isolate. The proposed mechanism involves CBD's effects on cellular stress responses and inflammation. The 25mg dose is modest compared to therapeutic CBD doses for epilepsy (200-300mg) or anxiety (300-600mg). Take CBD oil sublingually or mixed with food. Quality varies wildly in the CBD market. Look for products with third-party testing showing actual CBD content and confirming absence of THC above 0.3%.

Curcumin at 600mg daily requires taking it on an empty stomach according to Tippens. Regular curcumin has poor bioavailability, with less than 1% absorbed. Many people use enhanced formulations with piperine (black pepper extract), liposomal curcumin, or branded forms like Longvida or BCM-95. These increase absorption 20 to 100-fold. If using plain curcumin powder, you need the full 600mg. Enhanced formulations may work at lower doses like 200-400mg.

Tippens never mixed all components into one dose. He took fenbendazole with breakfast, vitamin E with lunch, CBD oil in the afternoon, and curcumin first thing in the morning before eating. This spacing has no proven benefit but prevents potential interactions and follows his exact pattern.

Cost for the complete stack runs approximately $150-250 monthly depending on product quality. Fenbendazole costs $40-80 monthly. Vitamin E costs $10-20. CBD oil costs $50-100 for a month's supply at 25mg daily. Curcumin costs $20-40. Generic or bulk options reduce costs. Premium or organic options increase them.

How Fenbendazole May Work in Human Cells

Fenbendazole belongs to the benzimidazole class of antiparasitic drugs. In parasites, it binds to tubulin proteins and prevents microtubule formation, disrupting cell division and glucose uptake. The parasite cannot maintain its cellular structure or energy production and dies.

Laboratory research suggests fenbendazole might affect mammalian cells differently than veterinary use implies. A 2018 study published in Scientific Reports showed fenbendazole reduced tumor growth in mice with non-small cell lung cancer. The mechanism involved microtubule disruption similar to chemotherapy drugs like paclitaxel, plus effects on cellular glucose metabolism. Cancer cells often rely heavily on glucose through a process called the Warburg effect. Fenbendazole appears to interfere with this metabolic pathway.

Additional research points to fenbendazole activating p53, a tumor suppressor gene that triggers programmed cell death in damaged cells. Many cancers disable p53. Reactivating it could help eliminate cancer cells. A 2008 study showed fenbendazole induced apoptosis in human cancer cell lines including lymphoma cells. These effects occurred at concentrations achievable with oral dosing in humans.

Fenbendazole may also prevent new blood vessel formation that tumors need to grow beyond a few millimeters. This anti-angiogenic effect appeared in studies of other benzimidazoles. The exact mechanism remains unclear but likely involves multiple cellular pathways rather than one target.

Does this laboratory evidence translate to humans with cancer? We do not know. Cell studies and mouse studies frequently fail to predict human outcomes. Drugs that shrink tumors in mice fail clinical trials 90% of the time. The doses used in mouse studies sometimes exceed what humans can safely achieve. The 222mg Tippens dose produces blood levels far below those used in most laboratory research.

No oncology organization recommends fenbendazole for cancer treatment. The National Cancer Institute lists it as an unapproved substance under investigation. Some researchers have proposed clinical trials but none have completed enrollment or published results as of 2024. Anyone considering this protocol should understand they are experimenting based on theory and anecdote, not proven medicine.

Safety Considerations and Side Effects

Fenbendazole has been used in animals for over 40 years with a strong safety profile at antiparasitic doses. Human data is limited to case reports and online testimonials, not systematic safety studies. The most common side effects reported by people following the Joe Tippens protocol include mild gastrointestinal upset, elevated liver enzymes, and occasional fatigue.

Digestive side effects happen in roughly 10-15% of users based on online surveys and forum reports. These include nausea, diarrhea, stomach cramping, and occasional constipation. Taking fenbendazole with food reduces these effects. Starting with a lower dose like 111mg and increasing to 222mg over two weeks helps some people adapt. The symptoms usually resolve within a few days as the body adjusts.

Liver enzyme elevation shows up in blood tests for a small percentage of users. AST and ALT may increase to 1.5 to 2 times the upper limit of normal. This typically occurs after several weeks of use and reverses when fenbendazole is stopped. Regular monitoring with a comprehensive metabolic panel every 4-8 weeks catches this early. Anyone with existing liver disease should exercise extreme caution and work closely with a physician. Combining fenbendazole with other medications metabolized by the liver increases risk.

Bone marrow suppression represents a theoretical concern. High-dose benzimidazoles can reduce white blood cell, red blood cell, and platelet production in animals. This has not appeared frequently in people taking the Tippens protocol dose, but complete blood counts every 8-12 weeks provide reassurance. Watch for unusual bruising, persistent fatigue, or frequent infections.

Drug interactions need consideration. Fenbendazole is metabolized by liver enzymes in the CYP450 system, particularly CYP1A2. Medications that inhibit or induce these enzymes may increase or decrease fenbendazole blood levels. Strong CYP1A2 inhibitors include fluvoxamine and ciprofloxacin. Inducers include smoking and chargrilled meats. The clinical significance remains unknown but deserves awareness.

Pregnancy and breastfeeding represent absolute contraindications. Benzimidazoles can cause fetal abnormalities in animals. No human safety data exists. Women of childbearing age should use reliable contraception while taking fenbendazole.

Long-term safety beyond two years lacks documentation. Tippens and others report taking the protocol for several years without serious adverse effects, but plural of anecdote is not data. Unknown risks may emerge with extended use. For more detailed safety information, see our comprehensive guide on fenbendazole safety for humans.

Accessing Fenbendazole in the United States

Fenbendazole is not FDA-approved for human use in the United States. It remains a veterinary medication available over the counter for deworming dogs, cats, and livestock. This regulatory status creates a gray area for people seeking it for off-label personal use.

Veterinary fenbendazole products like Panacur C, Safeguard, and other brands sell freely at farm supply stores, pet stores, and online retailers like Amazon or Chewy. These products contain fenbendazole mixed with inactive ingredients designed for animals. Many people following the Tippens protocol have used these veterinary products. The 222mg dose originated from the Panacur C canine dewormer packet size.

Pharmaceutical-grade fenbendazole formulated for research or compounding offers another option. Wormentel 888mg provides precisely measured doses in tablet form, manufactured to pharmaceutical standards rather than veterinary specifications. Each tablet can be split to achieve the 222mg protocol dose or taken as a 444mg dose for those following adjusted protocols. SafeRxPills ships pharmaceutical-grade fenbendazole to customers across the United States, providing a consistent and tested product.

Prices vary by source and formulation. Veterinary Panacur C costs approximately $50-70 for a 30-day supply at 222mg daily (you need 12 packets for a month following the three days on, four days off protocol). Pharmaceutical-grade products range from $60-120 for a month's supply depending on dose and manufacturer. Bulk powder fenbendazole sometimes sells for less but requires accurate measuring and lacks quality verification.

Legality deserves clarity. Possessing and personally using fenbendazole is legal in the United States. No law prohibits buying veterinary medications for personal use. However, no physician can legally prescribe it for cancer or other human conditions because it lacks FDA approval for such use. This means insurance will not cover it and you assume full responsibility for any adverse effects.

Some people import fenbendazole from international pharmacies. Quality control varies significantly with imported products. Contamination, incorrect dosing, and counterfeit products occur. SafeRxPills addresses this by providing verified pharmaceutical-grade products with consistent potency and purity. For detailed information on reliable sources, check our guide to buying fenbendazole in the USA.

Compounding pharmacies can prepare fenbendazole capsules with a physician's prescription, though many doctors hesitate to prescribe an unapproved drug for off-label use. These compounded preparations cost more but offer precise dosing and pharmaceutical-grade quality.

What to Monitor While Following the Protocol

Anyone taking fenbendazole should establish baseline measurements and monitor specific parameters regularly. This catches potential side effects early and provides objective data about any changes in health status.

Laboratory tests form the foundation of monitoring. Before starting, get a complete blood count, comprehensive metabolic panel, and liver function tests. These establish your baseline. Repeat the comprehensive metabolic panel and liver function tests every 4-8 weeks initially, extending to every 12 weeks after six months if results remain normal. Watch for AST or ALT above 2-3 times baseline. If this occurs, stop fenbendazole and retest in two weeks. The complete blood count should be checked every 8-12 weeks to monitor for bone marrow effects.

Symptom tracking helps identify patterns. Keep a simple log noting energy level, digestive symptoms, and any unusual changes. Rate energy on a 1-10 scale daily. Note bowel movements, nausea, or cramping. This creates a record that helps distinguish protocol effects from disease progression or other factors.

For people using this protocol alongside cancer treatment, standard tumor markers and imaging studies continue according to oncology recommendations. Do not substitute fenbendazole for proven treatments without informed consent and medical supervision. Some people use it as an addition to conventional therapy. Others use it when conventional options are exhausted. Document your reasoning and decision process.

Blood pressure deserves attention in the first month. Some users report temporary blood pressure changes. Check it weekly at home or a pharmacy for the first four weeks. Sustained elevation above 140/90 warrants medical consultation.

Weight tracking reveals whether the protocol affects appetite or metabolism. Weigh yourself weekly at the same time of day. Unintended weight loss exceeding five pounds in a month needs investigation. This could reflect disease progression, medication side effects, or inadequate nutrition.

If following both the ivermectin and fenbendazole protocol combined, additional monitoring becomes critical. The combination increases theoretical risk of drug interactions and side effects. More frequent blood work and closer symptom tracking provide safety margins.

Mental health matters too. Anxiety about cancer or uncertainty about experimental protocols takes a toll. Consider working with a counselor or joining support groups where people share experiences with alternative approaches. Isolation and stress undermine any treatment.

Frequently Asked Questions